This research study is studying a new blood test to screen for Epidermal Growth Factor Receptor (EGFR) positive lung cancer in healthy individuals at risk for the disease and who cannot undergo regular lung cancer screening. The name of the test used in this research study is: -Circulating free DNA (cfDNA) Assay
Lung Cancer, EGFR Gene Mutation
This research study is studying a new blood test to screen for Epidermal Growth Factor Receptor (EGFR) positive lung cancer in healthy individuals at risk for the disease and who cannot undergo regular lung cancer screening. The name of the test used in this research study is: -Circulating free DNA (cfDNA) Assay
EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
-
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States, 02215
Dana-Farber Cancer Institute, Boston, Massachusetts, United States, 02215
Massachusetts General Hospital, Boston, Massachusetts, United States, 02215
Dana-Farber Cancer Institute at Steward St. Elizabeth's, Brighton, Massachusetts, United States, 02135
Dana-Farber Cancer Instiute Merrimack Valley, Methuen, Massachusetts, United States, 01844
Dana-Farber Cancer Institute South Shore, South Weymouth, Massachusetts, United States, 02190
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
40 Years to 80 Years
ALL
Yes
Dana-Farber Cancer Institute,
Narjust Florez, MD, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute
2027-12-01